{
  "resourceType": "MedicinalProductDefinition",
  "id": "Voxra-150mg-Tablet-SE-BS-MedicinalProductDefinition",
  "meta": {
    "profile": [
      "http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"
    ]
  },
  "identifier": [
    {
      "system": "http://ema.europa.eu/fhir/mpId",
      "value": "SE-100000307-00023491"
    },
    {
      "system": "http://ema.europa.eu/fhir/eurdId",
      "value": "461"
    }
  ],
  "combinedPharmaceuticalDoseForm": {
    "coding": [
      {
        "code": "100000073668",
        "system": "https://spor.ema.europa.eu/v1/lists/200000000004~200000000006~200000000007~200000000008",
        "display": "Modified-release tablet"
      }
    ]
  },
  "domain": {
    "coding": [
      {
        "code": "100000000012",
        "system": "https://spor.ema.europa.eu/v1/lists/100000000004",
        "display": "Human use"
      }
    ]
  },
  "status": {
    "coding": [
      {
        "code": "200000005004",
        "system": "https://spor.ema.europa.eu/v1/lists/200000005003",
        "display": "Current"
      }
    ]
  },
  "indication": "Voxra är indicerat för behandling av egentlig depression.",
  "legalStatusOfSupply": {
    "coding": [
      {
        "code": "100000072084",
        "system": "https://spor.ema.europa.eu/v1/lists/100000072051",
        "display": "Medicinal product subject to medical prescription"
      }
    ]
  },
  "classification": [
    {
      "coding": [
        {
          "code": "100000097705",
          "system": "https://spor.ema.europa.eu/v1/lists/100000093533",
          "display": "N06AX12"
        }
      ]
    }
  ],
  "name": [
    {
      "productName": "Voxra 150 mg tablett med modifierad frisättning"
    }
  ]
}
